Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin
Open Access
- 1 January 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (1) , 21-24
- https://doi.org/10.1128/aac.34.1.21
Abstract
Single-dose administration of fleroxacin was evaluated as a means of preventing foreign body infection due to staphylococci. Tissue cages were implanted into guinea pigs and subsequently infected (100% rate) with 10(2) or more CFU of Staphylococcus aureus Wood 46. When a single dose of 30 mg of fleroxacin or vancomycin per kg of body weight was administered intraperitoneally, bactericidal levels of the antimicrobial agent were found in the tissue cage fluid after 3 h (when guinea pigs were inoculated with S. aureus) and during the next 24 h. Either fleroxacin or vancomycin successfully prevented experimental infection in all tissue cages challenged by 10(2) CFU of S. aureus Wood 46. When tissue cages were challenged with 10(4) CFU of S. aureus Wood 46, however, fleroxacin was more effective than vancomycin (P less than 0.05) in reducing colony counts below the detection limit of 10 CFU/ml in the inflammatory fluid of all tissue cages during the initial 48 h. In contrast to their initially different actions, the effects of the antibiotics were similar after 7 days, mostly because bacterial regrowth occurred more frequently in the fleroxacin-treated than in the vancomycin-treated tissue cages. These data show that experimental infections of subcutaneous tissue cages are a useful model for studying the prophylaxis of foreign body infections with antimicrobial agents.This publication has 17 references indexed in Scilit:
- In-vitro susceptibility of staphylococci to fleroxacin in comparison withsix other quinolonesJournal of Antimicrobial Chemotherapy, 1988
- In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinoloneJournal of Antimicrobial Chemotherapy, 1988
- Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacinJournal of Antimicrobial Chemotherapy, 1988
- Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1988
- Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.1987
- Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis.Journal of Bone and Joint Surgery, 1985
- Foreign Body Infection: Role of Fibronectin as a Ligand for the Adherence of Staphylococcus aureusThe Journal of Infectious Diseases, 1984
- Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.Journal of Clinical Investigation, 1984
- Short-Term Administration of Rifampin in the Prevention or Eradication of Infection Due to Foreign BodiesClinical Infectious Diseases, 1983
- Pathogenesis of Foreign Body Infection: Description and Characteristics of an Animal ModelThe Journal of Infectious Diseases, 1982